Effects of losartan, an angiotensin II receptor antagonist, on the fibrinolytic system in hypertensive patients

被引：0
|
作者：
Saito, M
Kawasaki, S
Hashiba, T
Chen, CJ
Hatakeyama, H
Asakura, H
Kikuchi, M
Matsuda, T
机构：
[1] Kanazawa W Hosp, Dept Internal Med, Kanazawa, Ishikawa 9200055, Japan
[2] Kanazawa Univ, Sch Med, Dept Internal Med 3, Kanazawa, Ishikawa 920, Japan
[3] Fukui Med Univ, Dept Internal Med 3, Fukui, Japan
来源：
INTERNATIONAL JOURNAL OF HEMATOLOGY | 1999年 / 70卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：60 / 61
页数：2
相关论文
共 50 条
  • [31] Effects of the angiotensin II type 1 receptor antagonist valsartan on the expression of superoxide dismutase in hypertensive patients
    Chan, Paul
    Ko, Wen-Chin
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 127 - 127
  • [32] Effects of a Fixed Combination of Losartan With Hydrochlorothiazide on Glucose Tolerance in Hypertensive Patients Uncontrolled with Angiotensin II Receptor Blockers Alone
    Yamamuro, Megumi
    Yamamoto, Koichiro
    Kan, Hirofumi
    Takashio, Seiji
    Tayama, Shinji
    Kaikita, Koichi
    Hokimoto, Seiji
    Sumida, Hitoshi
    Sugiyama, Seigo
    Ogawa, Hisao
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2013, 20 (03) : 238 - 244
  • [33] Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients
    Koh, KK
    Ahn, JY
    Han, SH
    Kim, DS
    Jin, DK
    Kim, HS
    Shin, MS
    Ahn, TH
    Choi, IS
    Shin, EK
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (05) : 905 - 910
  • [34] EFFECTS OF THE ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN ON 24-HOUR BLOOD-PRESSURE PROFILES OF PRIMARY AND SECONDARY HYPERTENSIVE RATS
    SCHNECKO, A
    WITTE, K
    LEMMER, B
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 26 (02) : 214 - 221
  • [35] DuP 532, an angiotensin II receptor antagonist: First administration and comparison with losartan
    Goldberg, MR
    Lo, MW
    Christ, DD
    Chiou, R
    Furtek, CI
    Amit, O
    Carides, A
    Biollaz, J
    Piguet, V
    Nussberger, J
    Brunner, HR
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (01) : 59 - 69
  • [36] ABSORPTION AND GLUCURONIDATION OF THE ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN BY THE RAT INTESTINE
    KRIETER, PA
    COLLETTI, AE
    MILLER, RR
    STEARNS, RA
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1995, 273 (02): : 816 - 822
  • [37] Uricosuric effect of the angiotensin II receptor antagonist losartan in heart transplant recipients
    Minghelli, G
    Seydoux, C
    Goy, JJ
    Burnier, M
    TRANSPLANTATION, 1998, 66 (02) : 268 - 271
  • [38] Effects of angiotensin II receptor antagonist, Losartan on the apoptosis, proliferation and migration of the human pancreatic stellate cells
    Liu, Wen-Bin
    Wang, Xing-Peng
    Wu, Kai
    Zhang, Ru-Ling
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (41) : 6489 - 6494
  • [39] THE ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN - A NEW ADVANCE IN THE TREATMENT OF HYPERTENSION
    LACOURCIERE, Y
    CANADIAN JOURNAL OF CARDIOLOGY, 1995, 11 : F45 - F48
  • [40] EFFECTS OF THE AT1 RECEPTOR ANTAGONIST LOSARTAN ON ANGIOTENSIN-II INDUCED HYPERTROPHY OF RAT CARDIOMYOCYTES
    MURPHY, DD
    SHEPARD, J
    SMITH, SG
    STEPHENS, GA
    FASEB JOURNAL, 1992, 6 (04): : A1261 - A1261
12345